AzTrials
AzTrials

Surgical SmokeNCT07161609

The Effect of Masks on Surgical Smoke Exposure

A study testing Particle counter in people with Surgical Smoke, run by Mersin University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Surgical smoke refers to the gaseous plume released into the air as a result of the thermal destruction of tissues by energy-based devices used in operating rooms. The composition of surgical smoke may include various organic compounds. Read more about this study

Who is it for?
Any age
Conditions the study is for
Surgical Smoke
What is being tested?
Particle counter
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2025to 30 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Use of electrocautery,
  • Duration of surgery longer than 2 hours,
  • Elective total or partial hip prosthesis procedures.

Who cannot join

  • No use of electrocautery,
  • Duration of surgery shorter than 2 hours,
  • Emergency total or partial hip prosthesis procedures.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Seher Gürdil Yılmaz, PhD. contact

+90 530 920 55 72

gurdil@mersin.edu.tr

Turkey (Türkiye)1 site
  • Mersin University

    Mersin, 33010

    Seher Gürdil Yılmaz, PhD., +90 530 920 55 72, gurdil@mersin.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Different Types of Masks on Surgical Smoke Exposure

Surgical smoke refers to the gaseous plume released into the air as a result of the thermal destruction of tissues by energy-based devices used in operating rooms. The composition of surgical smoke may include various organic compounds. In the literature, the most frequently identified chemical substances in surgical smoke are formaldehyde, acrolein, hydrocarbons, fatty acids, hydrocyanic acid, phenols, nitriles, acrylonitrile, hydrogen cyanide, benzene, and toluene. These particles can negatively affect the health of the operating room personnel. According to current guidelines, masks are recommended as the primary personal protective equipment to prevent respiratory exposure associated with surgical smoke. During surgical procedures, operating room staff frequently use surgical masks. Although surgical masks are the most commonly preferred personal protective equipment to protect healthcare workers against microorganisms and aerosols, they are unfortunately ineffective in filtering small particles. Therefore, the present study aimed to determine the impact of different types of masks on exposure to surgical smoke.

Read the detailed description

With the advancement of surgical techniques, the instruments and devices used in surgery have also rapidly evolved. Among these are energy-based devices that produce heat to achieve dissection or hemostasis during surgical procedures. Surgical smoke refers to the gaseous plume released into the air as a result of the thermal destruction of tissues by such devices, and is also termed cautery smoke, smoke plume, aerosol, or bioaerosol. While approximately 95% of surgical smoke consists of water vapor, the remaining 5% contains dead and viable cellular material, blood particles, viruses, bacteria, and toxic gases. The quantity and particle size of surgical smoke vary depending on factors such as the type of energy source, the tissue treated, and the duration and extent of treatment.

Surgical smoke has been identified by professional associations as a chemical hazard affecting the safety of operating room environments. Larger particles (≥5 μm) deposit in the nasal and oropharyngeal regions, particles of 2-5 μm can reach the airways, and particles <2 μm may penetrate lung tissue, accumulating in bronchioles and alveoli. Various toxic chemicals have been identified in surgical smoke, including formaldehyde, acrolein, hydrocarbons, fatty acids, hydrogen cyanide, phenols, nitriles, acrylonitrile, benzene, and toluene. Studies have also reported the presence of volatile organic compounds such as toluene, xylene, ethylbenzene, styrene, and naphthalene, with concentrations varying by procedure type.

Exposure to surgical smoke negatively impacts the health of operating room staff, with reported symptoms such as headaches, nausea, throat irritation, cough, eye problems, respiratory difficulties, dermatitis, and anxiety. To mitigate these risks, recommended measures include staff education, awareness programs, installation of smoke evacuation systems, use of personal protective equipment, and development of institutional protocols.

Among personal protective equipment, masks are the primary barrier recommended against respiratory exposure to surgical smoke. Although surgical masks are widely used to protect healthcare professionals against microorganisms and aerosols, they are largely ineffective in filtering fine particles. Professional guidelines advise the use of N95 respirators in conjunction with smoke evacuation systems, especially in procedures with high risk of viral transmission, given their superior filtration capacity.

However, studies specifically examining the effectiveness of different types of masks against surgical smoke remain limited, with most research focusing on mask performance during the COVID-19 pandemic. Experimental studies comparing filtration efficiency have demonstrated superior performance of N95/FFP2 respirators compared to surgical masks. In this context, the present study aims to investigate the effectiveness of different mask types in protecting operating room staff from surgical smoke exposure.

Conditions
Surgical Smoke
Being tested
Particle counter
Keywords
Surgical smoke, Particle, Mask, Operating room team

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Particle counterDevice

    The collection of air samples will begin with the surgical incision and will continue for 10 minute

Study groups in NCT07161609
Study groupRoleWhat they receive
Single surgical maskExperimentalDuring the surgery of patients undergoing hip prosthesis, an air sample will be collected to determine the particle count by attaching a single surgical mask to the tip of the particle counter.
Receives: Device: Particle counter
Double surgical maskExperimentalDuring the surgery of patients undergoing hip prosthesis, an air sample will be collected to determine the particle count by attaching a double surgical mask to the tip of the particle counter.
Receives: Device: Particle counter
N95 maskExperimentalDuring the surgery of patients undergoing hip prosthesis, an air sample will be collected to determine the particle count by attaching a N95 surgical mask to the tip of the particle counter.
Receives: Device: Particle counter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in airborne particle count

    Difference in particle count between masks

    Measured: The number of particles in the air collected during the 10 minutes following the initiation of the surgical incision.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2025
  2. Study start15 Oct 2025 (estimated)
  3. Primary completion28 Feb 2026 (estimated)
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective, parallel, three-arm, randomized controlled clinical trial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07161609
Sponsor's protocol ID
Different Types of Masks
Status last verified
Sep 2025
First submitted
5 Sep 2025
Last updated
8 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: In order to avoid duplication, it is not intended to be shared until the research is completed.

Publications

  • Dikmen Aydın, Y., Gürkan, A., & Kırtıl, İ. (2024). Cerrahi duman: Ameliyathanede çalışan sağlık profesyonellerine etkisi ve alınan önlemlerin incelenmesi. Sağlık ve Yaşam Bilimleri Dergisi, 6(1), 40-47.

Questions about this trial

What is this clinical trial studying?

A study testing Particle counter in people with Surgical Smoke, run by Mersin University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seher Gürdil Yılmaz, PhD. (+90 530 920 55 72, gurdil@mersin.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in airborne particle count (time frame: The number of particles in the air collected during the 10 minutes following the initiation of the surgical incision.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07161609, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in